标题
Antibiotics in the clinical pipeline in 2013
作者
关键词
-
出版物
JOURNAL OF ANTIBIOTICS
Volume 66, Issue 10, Pages 571-591
出版商
Springer Nature
发表日期
2013-09-04
DOI
10.1038/ja.2013.86
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden
- (2013) Mamun-Ur Rashid et al. ANAEROBE
- New β-lactam-β-lactamase inhibitor combinations in clinical development
- (2013) David M. Shlaes Annals of the New York Academy of Sciences
- Involvement of Fe Uptake Systems and AmpC β-Lactamase in Susceptibility to the Siderophore Monosulfactam BAL30072 in Pseudomonas aeruginosa
- (2013) Christian van Delden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections
- (2013) W. T. Prince et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PotentIn VitroAntibacterial Activity of DS-8587, a Novel Broad-Spectrum Quinolone, against Acinetobacter baumannii
- (2013) Saito Higuchi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers
- (2013) Jared L. Crandon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322
- (2013) Karen O'Dwyer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- N-Chloramines, a Promising Class of Well-Tolerated Topical Anti-Infectives
- (2013) Waldemar Gottardi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Perturbation of Staphylococcus aureus Gene Expression by the Enoyl-Acyl Carrier Protein Reductase Inhibitor AFN-1252
- (2013) Joshua B. Parsons et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftaroline-Avibactam Tested against Clinical Isolates Collected from U.S. Medical Centers in 2010-2011
- (2013) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Solithromycin Inhibition of Protein Synthesis and Ribosome Biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae
- (2013) Ward Rodgers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America
- (2013) H. W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination
- (2013) George G. Zhanel et al. DRUGS
- Developing new antibacterials through natural product research
- (2013) Herbert A Kirst Expert Opinion on Drug Discovery
- Peptides as the next generation of anti-infectives
- (2013) Derry K Mercer et al. Future Medicinal Chemistry
- Fungicidal photodynamic effect of a twofold positively charged porphyrin againstCandida albicansplanktonic cells and biofilms
- (2013) Fernanda Pereira Gonzales et al. Future Microbiology
- Antibiotics and antibiotic resistance: A bitter fight against evolution
- (2013) Alexandro Rodríguez-Rojas et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli
- (2013) B. Hofer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria
- (2013) Elizabeth MH Wellington et al. LANCET INFECTIOUS DISEASES
- Natural products emergent
- (2013) Daniel Grushkin NATURE MEDICINE
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Process R&D of Eravacycline: The First Fully Synthetic Fluorocycline in Clinical Development
- (2013) Magnus Ronn et al. ORGANIC PROCESS RESEARCH & DEVELOPMENT
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of LTX-109, a Synthetic Antimicrobial Peptide, against Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, Daptomycin-Nonsusceptible, and Linezolid-Nonsusceptible Staphylococcus aureus
- (2012) Louis D. Saravolatz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of a Novel Cyclic Lipopeptide, CB-183,315, against Resistant Clostridium difficile and Other Gram-Positive Aerobic and Anaerobic Intestinal Pathogens
- (2012) D. R. Snydman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VitroActivities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria
- (2012) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette ChromosomemecTypes
- (2012) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers
- (2012) Lillian S. L. Ting et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroandIn VivoCharacterization of CB-183,315, a Novel Lipopeptide Antibiotic for Treatment of Clostridium difficile
- (2012) Carmela T. M. Mascio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?
- (2012) Daniel Golparian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections
- (2012) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of and Mechanism of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compound LFF571
- (2012) J. A. Leeds et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode of Action,In VitroActivity, andIn VivoEfficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
- (2012) Nachum Kaplan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections
- (2012) Gary J. Noel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
- (2012) Trudy H. Grossman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial mechanism of lantibiotics
- (2012) Mohammad R. Islam et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Recent development of potent analogues of oxazolidinone antibacterial agents
- (2012) Katarzyna Michalska et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A comprehensive summary of LL-37, the factotum human cathelicidin peptide
- (2012) Dieter Vandamme et al. CELLULAR IMMUNOLOGY
- Emergence of antibiotic resistance: need for a new paradigm
- (2012) J.M. Rolain et al. CLINICAL MICROBIOLOGY AND INFECTION
- Screening Strategies to Identify New Antibiotics
- (2012) Mark S. Butler et al. CURRENT DRUG TARGETS
- Resolving Biofilm Infections: Current Therapy and Drug Discovery Strategies
- (2012) Max V. Ranall et al. CURRENT DRUG TARGETS
- UDP-3-O-(R-3-hydroxymyristoyl)-N-Acetylglucosamine Deacetylase (LpxC) Inhibitors: A New Class of Antibacterial Agents
- (2012) J. Zhang et al. CURRENT MEDICINAL CHEMISTRY
- New classes of antibiotics
- (2012) Donald T Moir et al. CURRENT OPINION IN PHARMACOLOGY
- Overcoming the challenges to developing new antibiotics
- (2012) David M Shlaes et al. CURRENT OPINION IN PHARMACOLOGY
- New horizons for host defense peptides and lantibiotics
- (2012) Michael John Dawson et al. CURRENT OPINION IN PHARMACOLOGY
- Improving known classes of antibiotics: an optimistic approach for the future
- (2012) Karen Bush CURRENT OPINION IN PHARMACOLOGY
- Evolution of antibiotic resistance at non-lethal drug concentrations
- (2012) Dan I. Andersson et al. DRUG RESISTANCE UPDATES
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency
- (2012) Zeina A. Kanafani et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA
- (2012) Mark W Garrison et al. Expert Review of Anti-Infective Therapy
- Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
- (2012) George G Zhanel et al. Expert Review of Anti-Infective Therapy
- Thoughts and facts about antibiotics: Where we are now and where we are heading
- (2012) János Bérdy JOURNAL OF ANTIBIOTICS
- Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection
- (2012) G. S. Crowther et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)
- (2012) H. S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii
- (2012) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of Plazomicin (ACHN-490) against MDR clinical isolates ofKlebsiella pneumoniae, Escherichia coli, andEnterobacterspp. from Athens, Greece
- (2012) Irene Galani et al. JOURNAL OF CHEMOTHERAPY
- Head-to-Head Prenyl Tranferases: Anti-Infective Drug Targets
- (2012) Fu-Yang Lin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
- (2012) Matthew J. LaMarche et al. JOURNAL OF MEDICINAL CHEMISTRY
- The critical impact of time discounting on economic incentives to overcome the antibiotic market failure
- (2012) Brad Spellberg et al. NATURE REVIEWS DRUG DISCOVERY
- 35 years of resistance
- (2012) NATURE REVIEWS MICROBIOLOGY
- Modulating immunity as a therapy for bacterial infections
- (2012) Robert E. W. Hancock et al. NATURE REVIEWS MICROBIOLOGY
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibiotics in development targeting protein synthesis
- (2011) Joyce A. Sutcliffe Annals of the New York Academy of Sciences
- Are pleuromutilin antibiotics finally fit for human use?
- (2011) Rodger Novak Annals of the New York Academy of Sciences
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- Human Pharmacokinetics and Safety Profile of Finafloxacin, a New Fluoroquinolone Antibiotic, in Healthy Volunteers
- (2011) Heena Patel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ComparativeIn VitroActivities of the Novel Antibacterial Finafloxacin against Selected Gram-Positive and Gram-Negative Bacteria Tested in Mueller-Hinton Broth and Synthetic Urine
- (2011) Axel Dalhoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Susceptibility of ClinicalMycobacterium tuberculosisIsolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480
- (2011) J. W. C. Alffenaar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antistaphylococcal Activities of the New Fluoroquinolone JNJ-Q2
- (2011) Brian J. Morrow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species
- (2011) Diane M. Citron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSpectrum of Activity of Finafloxacin, a Novel, pH-Activated Fluoroquinolone, under Standard and Acidic Conditions
- (2011) Will Stubbings et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Solid state of CG-400549, a novel FabI inhibitor: Characterization, dissolution, transformation
- (2011) Bo-Yeon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Urinary Pharmacokinetics and Bactericidal Activity of Finafloxacin (200 and 800 mg) in Healthy Volunteers Receiving a Single Oral Dose
- (2011) Florian M.E. Wagenlehner et al. CHEMOTHERAPY
- Challenges of Antibacterial Discovery
- (2011) L. L. Silver CLINICAL MICROBIOLOGY REVIEWS
- Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
- (2011) Ken Coleman CURRENT OPINION IN MICROBIOLOGY
- Towards new business models for R&D for novel antibiotics
- (2011) A.D. So et al. DRUG RESISTANCE UPDATES
- Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
- (2011) Weon Bin Im et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent derivatives from smaller classes of fermentation-derived antibacterials
- (2011) Herbert A Kirst EXPERT OPINION ON THERAPEUTIC PATENTS
- Substrate specificity of the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis responsible for the bioreductive activation of bicyclic nitroimidazoles
- (2011) Meera Gurumurthy et al. FEBS Journal
- In vitro activity of BAL30072 against Burkholderia pseudomallei
- (2011) Takehiko Mima et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents
- (2011) Meng-Shuian Hsu et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
- (2011) Fred C. Tenover et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Preserving the Lifesaving Power of Antimicrobial Agents
- (2011) James M. Hughes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antibiotics in the clinical pipeline in 2011
- (2011) Mark S Butler et al. JOURNAL OF ANTIBIOTICS
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
- (2011) Johan Isaksson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 2. Optimization of the C-9 Side-Chain for Antibacterial Activity and Oral Efficacy
- (2011) Roger B. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
- (2011) Xiao-Yi Xiao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fix the antibiotics pipeline
- (2011) Matthew A. Cooper et al. NATURE
- Antibacterial R&D incentives
- (2011) Ramanan Laxminarayan et al. NATURE REVIEWS DRUG DISCOVERY
- A Concise Synthesis of a β-Lactamase Inhibitor
- (2011) Ian K. Mangion et al. ORGANIC LETTERS
- Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
- (2010) D. Bertrand et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacokinetics of the Novel Biaryloxazolidinone Radezolid in Phagocytic Cells: Studies with Macrophages and Polymorphonuclear Neutrophils
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila
- (2010) S. Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and In Vivo Activities of LCB01-0371, a New Oxazolidinone
- (2010) J.-W. Jeong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone
- (2010) B. J. Morrow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of the Investigational Fluoroquinolone Finafloxacin against Ciprofloxacin-Sensitive and -Resistant Acinetobacter baumannii Isolates
- (2010) P. G. Higgins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non- -Lactam -Lactamase Inhibitor
- (2010) T. Stachyra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-ResistantStaphylococcus aureusIsolates during a 55-Passage Study
- (2010) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis
- (2010) Robert S. Wallis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
- (2010) M. G. P. Page et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and Spectrum of the Neoglycoside ACHN-490
- (2010) J. B. Aggen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin againstStaphylococcus aureus
- (2010) Sandrine Lemaire et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Challenges in Anti‐Infective Development in the Era of Bad Bugs, No Drugs: A Regulatory Perspective Using the Example of Bloodstream Infection as an Indication
- (2010) Helen W. Boucher CLINICAL INFECTIOUS DISEASES
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- The transcription inhibitor lipiarmycin blocks DNA fitting into the RNA polymerase catalytic site
- (2010) Audrey Tupin et al. EMBO JOURNAL
- Oritavancin: a novel lipoglycopeptide active against Gram-positive pathogens including multiresistant strains
- (2010) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae
- (2010) Hee Soo Park et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species
- (2010) David J. Farrell et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis
- (2010) Sakawarat Kanthawong et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial characterisation of solithromycin (CEM-101), a novel fluoroketolide: activity against staphylococci and enterococci
- (2010) Shannon D. Putnam et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362
- (2010) Steven Boakes et al. JOURNAL OF ANTIBIOTICS
- Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance
- (2010) Nadine-C. Emrich et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
- (2010) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The in vitro evaluation of solithromycin (CEM-101) against pathogens isolated in the United States and Europe (2009)
- (2010) David J. Farrell et al. JOURNAL OF INFECTION
- Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers
- (2010) Robert S. Wallis et al. JOURNAL OF INFECTIOUS DISEASES
- Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
- (2010) N. Srinivas et al. SCIENCE
- De Novo Design of Antimicrobial Polymers, Foldamers, and Small Molecules: From Discovery to Practical Applications
- (2009) Gregory N. Tew et al. ACCOUNTS OF CHEMICAL RESEARCH
- In Vivo Characterization of the Peptide Deformylase Inhibitor LBM415 in Murine Infection Models
- (2009) C. S. Osborne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AFN-1252, a FabI Inhibitor, Demonstrates a Staphylococcus-Specific Spectrum of Activity
- (2009) J. A. Karlowsky et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)
- (2009) J. B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stieglitz rearrangement of N,N-dichloro-β,β-disubstituted taurines under mild aqueous conditions
- (2009) Timothy P. Shiau et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Quaternary ammonium N,N-dichloroamines as topical, antimicrobial agents
- (2009) Charles Francavilla et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cost‐Effectiveness of Daptomycin versus Vancomycin and Gentamicin for Patients with Methicillin‐ResistantStaphylococcus aureusBacteremia and/or Endocarditis
- (2009) S. M. Bhavnani et al. CLINICAL INFECTIOUS DISEASES
- Quinolones: Action and Resistance Updated
- (2009) Karl Drlica et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Amadacycline
- (2009) Y. Wang et al. DRUGS OF THE FUTURE
- Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery
- (2009) Anshika Sharma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
- (2009) N. Ooi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters
- (2009) S. Mushtaq et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide
- (2009) Hong Bing Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal structures of pyridine-4-aldehyde thiosemicarbazone perchlorate and trifluoromethane sulfonate
- (2009) A. I. Smolentsev et al. JOURNAL OF STRUCTURAL CHEMISTRY
- Public–private partnership tackles TB challenges in parallel
- (2009) Sarah Webb NATURE REVIEWS DRUG DISCOVERY
- A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
- (2009) Michael T Guskey et al. PHARMACOTHERAPY
- De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers
- (2009) S. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibitors of FabI, an Enzyme Drug Target in the Bacterial Fatty Acid Biosynthesis Pathway
- (2008) Hao Lu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
- (2008) A. C. Haagsma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activities of the Rx-01 Oxazolidinones against Hospital and Community Pathogens
- (2008) L. Lawrence et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- R -01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
- (2008) E. Skripkin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types
- (2008) S. S. Bhagwat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: Discovery of FR264205
- (2008) Ayako Toda et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design at the atomic level: Generation of novel hybrid biaryloxazolidinones as promising new antibiotics
- (2008) Jiacheng Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antimicrobial Activities of Twenty Lysine-Peptoid Hybrids against Clinically Relevant Bacteria and Fungi
- (2008) Trine S. Ryge et al. CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains
- (2008) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Are natural products still the best source for antibacterial discovery? The bacterial entry factor
- (2008) Lynn L Silver Expert Opinion on Drug Discovery
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
- (2008) Rosemarie O’Shea et al. JOURNAL OF MEDICINAL CHEMISTRY
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines
- (2008) Lu Wang et al. TETRAHEDRON LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started